Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
COMPUGEN LTD
High uncertainty: The valuation methods show significant disagreement (>100% spread). Treat the range as a rough guide rather than a precise estimate.
Bear Case (25th pct.)
27.6% vs price
Base Case (Median)
67.2% vs price
Bull Case (75th pct.)
194.8% vs price
◇ = Current price | | Bear | Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $2.93 | 26.1% | High (40%) |
| PE Comparable | $8.53 | 267.8% | Medium (25%) |
| Graham Number | $3.05 | 31.3% | Medium (40%) |
| EV/EBITDA | $4.72 | 103.3% | Medium (20%) |
| EV/FCF | $7.55 | 225.3% | Medium (20%) |
| Earnings Power Value | $0.98 | -57.6% | Medium (50%) |
Based on 6 out of 7 methods, CGEN appears undervalued at the current price of $2.32. The base case fair value of $3.88 implies 67.2% upside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.